nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acceptance of adjuvant therapy and quality of life issues
|
Fallowfield, Lesley |
|
2005 |
14 |
6 |
p. 612-616 5 p. |
artikel |
2 |
Adjuvant chemotherapy for breast cancer—“one fits all”?
|
Bergh, Jonas |
|
2005 |
14 |
6 |
p. 564-569 6 p. |
artikel |
3 |
Adjuvant chemotherapy in 2005: Standards and beyond
|
Piccart, M.J. |
|
2005 |
14 |
6 |
p. 439-445 7 p. |
artikel |
4 |
Adjuvant endocrine therapies for postmenopausal women with early breast cancer: Standards and not
|
Dellapasqua, Silvia |
|
2005 |
14 |
6 |
p. 555-563 9 p. |
artikel |
5 |
Adjuvant endocrine therapies for pre-/perimenopausal women
|
Pritchard, Kathleen I. |
|
2005 |
14 |
6 |
p. 547-554 8 p. |
artikel |
6 |
Adjuvant endocrine therapy in postmenopausal breast cancer patients
|
Köberle, Dieter |
|
2005 |
14 |
6 |
p. 446-451 6 p. |
artikel |
7 |
Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy
|
Munoz, Raquel |
|
2005 |
14 |
6 |
p. 466-479 14 p. |
artikel |
8 |
Antibodies and vaccines–hope or illusion?
|
Jäger, Dirk |
|
2005 |
14 |
6 |
p. 631-635 5 p. |
artikel |
9 |
Biological variables and prognosis of DCIS
|
van de Vijver, Marc J. |
|
2005 |
14 |
6 |
p. 509-519 11 p. |
artikel |
10 |
Breast cancer control: Signs of progress, but more work required
|
Boyle, Peter |
|
2005 |
14 |
6 |
p. 429-438 10 p. |
artikel |
11 |
Endocrine responsiveness: Understanding how progesterone receptor can be used to select endocrine therapy
|
Osborne, C. Kent |
|
2005 |
14 |
6 |
p. 458-465 8 p. |
artikel |
12 |
Histopathology of primary breast cancer 2005
|
Viale, Giuseppe |
|
2005 |
14 |
6 |
p. 487-492 6 p. |
artikel |
13 |
Intraoperative electron beam radiotherapy (ELIOT) to the breast: A need for a quality assurance programme
|
Orecchia, R. |
|
2005 |
14 |
6 |
p. 541-546 6 p. |
artikel |
14 |
Limiting breast surgery to the proper minimum
|
Morrow, Monica |
|
2005 |
14 |
6 |
p. 523-526 4 p. |
artikel |
15 |
Management of women at high risk for breast cancer: New imaging beyond mammography
|
Kuhl, C.K. |
|
2005 |
14 |
6 |
p. 480-486 7 p. |
artikel |
16 |
Meeting highlights
|
|
|
2005 |
14 |
6 |
p. 643- 1 p. |
artikel |
17 |
Predicting response to systemic treatments: Learning from the past to plan for the future
|
Regan, Meredith M. |
|
2005 |
14 |
6 |
p. 582-593 12 p. |
artikel |
18 |
Preoperative (neoadjuvant) systemic treatment of breast cancer
|
Kaufmann, Manfred |
|
2005 |
14 |
6 |
p. 576-581 6 p. |
artikel |
19 |
Prognostic and predictive factors revisited
|
Hayes, Daniel F. |
|
2005 |
14 |
6 |
p. 493-499 7 p. |
artikel |
20 |
Sentinel lymph node biopsy for localised ductal carcinoma in situ?
|
Veronesi, P. |
|
2005 |
14 |
6 |
p. 520-522 3 p. |
artikel |
21 |
Special issues related to breast cancer adjuvant therapy in older women
|
Witherby, S.M. |
|
2005 |
14 |
6 |
p. 600-611 12 p. |
artikel |
22 |
Special issues related to the adjuvant therapy in very young women
|
Aebi, Stefan |
|
2005 |
14 |
6 |
p. 594-599 6 p. |
artikel |
23 |
Standards for follow-up care of patients with breast cancer
|
Peppercorn, Jeffery |
|
2005 |
14 |
6 |
p. 500-508 9 p. |
artikel |
24 |
The apoptotic action of estrogen following exhaustive antihormonal therapy: A new clinical treatment strategy
|
Jordan, V. Craig |
|
2005 |
14 |
6 |
p. 624-630 7 p. |
artikel |
25 |
The best use of adjuvant chemotherapy: New drugs and new use of “old” drugs
|
Hudis, Clifford |
|
2005 |
14 |
6 |
p. 570-575 6 p. |
artikel |
26 |
The biology of steroid hormones and endocrine treatment of breast cancer
|
Dowsett, Mitch |
|
2005 |
14 |
6 |
p. 452-457 6 p. |
artikel |
27 |
The International Breast Cancer Treatment Consensus St. Gallen-2005: Departure to new risk selection and new treatment options
|
Senn, Hans-Jörg |
|
2005 |
14 |
6 |
p. 427-428 2 p. |
artikel |
28 |
What extent of radiation therapy is standard?
|
Bellon, Jennifer R. |
|
2005 |
14 |
6 |
p. 532-540 9 p. |
artikel |
29 |
When mastectomy becomes inevitable: The nipple-sparing approach
|
Petit, J.Y. |
|
2005 |
14 |
6 |
p. 527-531 5 p. |
artikel |
30 |
When to recommend and to pay for first-line adjuvant breast cancer treatment? A structured review of the literature
|
Kilian, Reinhold |
|
2005 |
14 |
6 |
p. 636-642 7 p. |
artikel |
31 |
When will more useful predictive factors be ready for use?
|
Mauriac, Louis |
|
2005 |
14 |
6 |
p. 617-623 7 p. |
artikel |